173 related articles for article (PubMed ID: 21570635)
21. Relevance of TSH receptor stimulating and blocking autoantibody measurement for the prediction of relapse in Graves' disease.
Schott M; Minich WB; Willenberg HS; Papewalis C; Seissler J; Feldkamp J; Bergmann A; Scherbaum WA; Morgenthaler NG
Horm Metab Res; 2005 Dec; 37(12):741-4. PubMed ID: 16372227
[TBL] [Abstract][Full Text] [Related]
22. TSBAb (TSH-stimulation blocking antibody) and TSAb (thyroid stimulating antibody) in TSBAb-positive patients with hypothyroidism and Graves' patients with hyperthyroidism.
Takasu N; Yamashiro K; Ochi Y; Sato Y; Nagata A; Komiya I; Yoshimura H
Horm Metab Res; 2001 Apr; 33(4):232-7. PubMed ID: 11383928
[TBL] [Abstract][Full Text] [Related]
23. Thyroid cancer yield in patients with Graves' disease.
Stocker DJ; Burch HB
Minerva Endocrinol; 2003 Sep; 28(3):205-12. PubMed ID: 14605602
[TBL] [Abstract][Full Text] [Related]
24. Measurement of anti-TSH receptor antibodies: what is the correct cut-off value?
Smit MA; van Kinschot CMJ; van der Linden J; van Noord C; Kos S
Neth J Med; 2020 Mar; 78(2):55-63. PubMed ID: 32332174
[TBL] [Abstract][Full Text] [Related]
25. [Current topics on immunological laboratory tests-thyroid diseases].
Iwatani Y
Rinsho Byori; 2004 Sep; 52(9):751-8. PubMed ID: 15552935
[TBL] [Abstract][Full Text] [Related]
26. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A
Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515
[TBL] [Abstract][Full Text] [Related]
27. Improved prediction of relapse of Graves' thyrotoxicosis by combined determination of TSH receptor and thyroperoxidase antibodies.
Schott M; Eckstein A; Willenberg HS; Nguyen TB; Morgenthaler NG; Scherbaum WA
Horm Metab Res; 2007 Jan; 39(1):56-61. PubMed ID: 17226115
[TBL] [Abstract][Full Text] [Related]
28. Partial characterization and clinical correlation of circulating human immunoglobulins directed against thyrotrophin binding sites in guinea pig fat cell membranes. Development of a direct enzyme immunoassay.
Baker JR; Lukes YG; Smallridge RC; Berger M; Burman KD
J Clin Invest; 1983 Oct; 72(4):1487-97. PubMed ID: 6138364
[TBL] [Abstract][Full Text] [Related]
29. Partial prediction of postpartum Graves' thyrotoxicosis by sensitive bioassay for thyroid-stimulating antibody measured in early pregnancy.
Ide A; Amino N; Nishihara E; Kudo T; Ito M; Kimura Y; Tatsumi N; Yamazaki M; Miyauchi A
Endocr J; 2016 Oct; 63(10):929-932. PubMed ID: 27432817
[TBL] [Abstract][Full Text] [Related]
30. The negative correlation between thyrotropin receptor-stimulating antibodies and bone mineral density in postmenopausal patients with Graves' disease.
Amashukeli M; Korinteli M; Zerekidze T; Jikurauli N; Shanava S; Tsagareli M; Giorgadze E
J Investig Med; 2013 Jun; 61(5):842-7. PubMed ID: 23612147
[TBL] [Abstract][Full Text] [Related]
31. Performance of a third-generation TSH-receptor antibody in a UK clinic.
Theodoraki A; Jones G; Parker J; Woolman E; Martin N; Perera S; Thomas M; Bunn C; Khoo B; Bouloux PM; Vanderpump MP
Clin Endocrinol (Oxf); 2011 Jul; 75(1):127-33. PubMed ID: 21521291
[TBL] [Abstract][Full Text] [Related]
32. [Silent thyroiditis and subacute thyroiditis].
Noh JY
Nihon Rinsho; 2012 Nov; 70(11):1945-50. PubMed ID: 23214066
[TBL] [Abstract][Full Text] [Related]
33. Thyrotropin Receptor Antibody Levels at Diagnosis and After Thionamide Course Predict Graves' Disease Relapse.
Tun NN; Beckett G; Zammitt NN; Strachan MW; Seckl JR; Gibb FW
Thyroid; 2016 Aug; 26(8):1004-9. PubMed ID: 27266892
[TBL] [Abstract][Full Text] [Related]
34. The Role of Cytotoxic T-lymphocyte-associated Protein 4 (CTLA-4) Gene, Thyroid Stimulating Hormone Receptor (TSHR) Gene and Regulatory T-cells as Risk Factors for Relapse in Patients with Graves Disease.
Eliana F; Suwondo P; Asmarinah A; Harahap A; Djauzi S; Prihartono J; Pemayun TGD
Acta Med Indones; 2017 Jul; 49(3):195-204. PubMed ID: 29093229
[TBL] [Abstract][Full Text] [Related]
35. Clinical applications of the 2nd generation assay for anti-TSH receptor antibodies in Graves' disease. Evaluation in patients with negative 1st generation test.
Giovanella L; Ceriani L; Garancini S
Clin Chem Lab Med; 2001 Jan; 39(1):25-8. PubMed ID: 11256796
[TBL] [Abstract][Full Text] [Related]
36. Juvenile Graves disease: usefulness and limitations of thyrotropin receptor antibody determinations.
Foley TP; White C; New A
J Pediatr; 1987 Mar; 110(3):378-86. PubMed ID: 2880956
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of a new rapid and fully automated electrochemiluminescence immunoassay for thyrotropin receptor autoantibodies.
Yoshimura Noh J; Miyazaki N; Ito K; Takeda K; Hiramatsu S; Morita S; Miyauchi A; Murakami T; Inomata K; Noguchi S; Satoh T; Amino N
Thyroid; 2008 Nov; 18(11):1157-64. PubMed ID: 19014323
[TBL] [Abstract][Full Text] [Related]
38. Persistent high TRAb values during pregnancy predict increased risk of neonatal hyperthyroidism following radioiodine therapy for refractory hyperthyroidism.
Hamada N; Momotani N; Ishikawa N; Yoshimura Noh J; Okamoto Y; Konishi T; Ito K; Ito K
Endocr J; 2011; 58(1):55-8. PubMed ID: 20962435
[TBL] [Abstract][Full Text] [Related]
39. Impact of thyrotropin receptor antibody levels on fetal development in two successive pregnancies in a woman with Graves' disease.
Bjørgaas MR; Farstad H; Christiansen SC; Blaas HG
Horm Res Paediatr; 2013; 79(1):39-43. PubMed ID: 23154300
[TBL] [Abstract][Full Text] [Related]
40. Clinical performance of the Roche cobas e411 automated assay system for thyrotropin-receptor antibodies for the diagnosis of Graves' disease.
Syme NR; Toft AD; Stoddart M; Beckett GJ
Ann Clin Biochem; 2011 Sep; 48(Pt 5):471-3. PubMed ID: 21813574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
